Moving this up to a new thread for more visibility... . We cloned and Sanger sequenced some standard genomic PE libraries and are seeing truncation of the adapters from the 5' end in some libraries, as well as a larger number of molecules containing full PE1 sequences than full PE2 sequences. We used NEB library preparation kits and some custom barcoded adapters from Invitrogen, which contained the phosphothiorate modification and were purified using desalting. Following triplicate 4 cycle PCR (we also tested 8 and 12 cycle PCR but saw little difference in this respect), we cloned several of the libraries into the Fermentas blunt end pJet vector and Sanger sequenced several transformants. While some clones looked normal, several had truncations off the 5' end of PE1 (see attachments). These truncated sequences did contain some bases from the PCR primer on both sides, meaning that we weren't just sequencing unamplified ligated molecules, and there were no adapter-only clones. I haven't been able to come up with a reason why the primers themselves should be truncated aside from being poorly synthesized- but that surprises me since I have not had similar problems with Invitrogen oligos in the past. We are not sure what steps to take next- should we just qPCR quantify the libraries with Kapa so we know how many correct molecules are present and use that to estimate loading amounts? Or did we go wrong elsewhere in library prep?
Unconfigured Ad
Collapse
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|